AIC
CGTX icon

AWM Investment Company’s Cognition Therapeutics CGTX Stock Holding History

AWM Investment Company’s Portfolio CGTX Stock Details CGTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-650,000
Closed -$1.08M – 99
2024
Q2 		$1.08M Hold
650,000
– – 0.15% 83
2024
Q1 		$1.18M Buy
+650,000
New +$1.34M 0.15% 87

Other funds holding CGTX

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
CM
CM Management Gulf Breeze, Florida $120M AUM 37.12% 1-Year Est. Return
AFG
American Financial Group Cincinnati, Ohio $270M AUM 3.25% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
SPC
Sigma Planning Corp Ann Arbor, Michigan $3.6B AUM 24.57% 1-Year Est. Return
KAS
Kestra Advisory Services Austin, Texas $31B AUM 28.39% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

AWM Investment Company's CGTX Position: Q3 2024 in Review

AWM Investment Company sold out of Cognition Therapeutics (CGTX) in Q3 2024, closing a stake of 650,000 shares — an estimated $1.08M sold.

AWM Investment Company first reported a position in CGTX in Q1 2024 and held it in 2 quarters. The position peaked at $1.18M in Q1 2024. 40 funds tracked by Wall St. Rank hold CGTX as of Q3 2024.

  • AWM Investment Company reported no remaining Cognition Therapeutics position as of Q3 2024 after selling out during the quarter.
  • AWM Investment Company sold 650,000 Cognition Therapeutics shares in Q3 2024, an estimated $1.08M.
  • AWM Investment Company first reported a position in Cognition Therapeutics in Q1 2024 and held it in 2 quarters.
  • AWM Investment Company's Cognition Therapeutics position peaked at $1.18M in Q1 2024.
  • 40 funds tracked by Wall St. Rank held Cognition Therapeutics as of Q3 2024.

Based on AWM Investment Company's 13F filing for Q3 2024, filed 14 Nov 2024.